CARDIAC POSITRON EMISSION TOMOGRAPHY TO QUANTIFY ABNORMAL CORONARY FLOW RESERVE AND RISK STRATIFY A PROSPECTIVE COHORT OF END STAGE RENAL DISEASE PATIENTS

CARDIAC POSITRON EMISSION TOMOGRAPHY TO QUANTIFY ABNORMAL CORONARY FLOW RESERVE AND RISK STRATIFY A PROSPECTIVE COHORT OF END STAGE RENAL DISEASE PATIENTS

Methods We prospectively studied 131 patients who had rest/dipyridamole pharmacologic stress N13-ammonia positron emission tomography myocardial perfusion imaging (PET) for kidney transplant evaluation. 34 patients also had left heart catheterization (LHC).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1618-1618
Hauptverfasser: Paz, Yehuda, Morgenstern, Rachelle, Weinberg, Richard, Chiles, Mariana, Bhatti, Navdeep, Ali, Ziad, Mohan, Sumit, Bokhari, Sabahat
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Cardiovascular disease
Internal Medicine
Ischemia
Kidney diseases
Medicare
Tomography
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods We prospectively studied 131 patients who had rest/dipyridamole pharmacologic stress N13-ammonia positron emission tomography myocardial perfusion imaging (PET) for kidney transplant evaluation. 34 patients also had left heart catheterization (LHC).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)31619-9